Springbok Capital Management »

ImmunoGen shares owned by Springbok Capital Management

Quarter-by-quarter ownership of ImmunoGen shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2011-03-31 $27k 3.0k 9.00

More positions owned by Springbok Capital Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Tesla Motors (TSLA)
Activision Blizzard Call Option
Horizon Therapeutics Pub L SHS Call Option
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Consol Energy (CEIX)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Brighthouse Finl (BHF)
Netease Sponsored Ads (NTES)
Bio Rad Labs Cl A (BIO)
Select Sector Spdr Tr Sbi Int-utils Put Option (XLU)
Trip Com Group Ads (TCOM)

View all positions for Springbok Capital Management

Top funds holding ImmunoGen

Vanguard Group
RA Capital Management
Redmile Group
Henderson Group
Pentwater Capital Management
Fairmount Funds Management
Norges Bank Investment Management
Millennium Management
D. E. Shaw & Co
Balyasny Asset Management
Voloridge Investment Management
Boxer Capital
Maverick Capital
TIG Advisors
Tang Capital Management

View all funds holding ImmunoGen